SHARPIN and melanoma: demonstrated that SIPL1 expression was elevated in human melanoma tissues and SIPL1 overexpression promoted melanoma development and progression via the p38 and c-Jun N-terminal kinases (JNK)/c-Jun signaling pathways (7).